| |JULY 202619POWERING REGENERATIVE INNOVATION· Acadicell's integrated innovation model unites education, scientific research, product devel-opment, and commercialization to accelerate the translation of regenerative medicine from laboratory discovery to patient care.· Its efforts are supported by a Class 10000 clean-room facility and specialized expertise in stem cell culture, molecular biology, cytogenetics, flow cytometry, and cell characterization.· The company's focus on scalable Impact drives initiatives like developing regenerative medi-cine platforms across stem cell technologies, exosomes, hematopoietic stem cell expansion, and amniotic membrane-derived products. "At Acadicell, we view commercialization not as the final step of research, but as a carefully planned journey that begins from the earliest stages of innovation", states Dr Raghu Babu.By integrating research, regulation, collaboration, and commercialization into a single development framework, Acadicell is creating regenerative technologies designed not just to demonstrate scientific promise but to reach the patients who need them.Future Defined by Scientific IntegrityAs regenerative medicine continues to evolve, trust will remain as important as innovation. Acadicell has therefore built its culture around scientific integrity, ethical responsibility, and continuous learning. The company follows evidence-based methodologies, rigorous validation processes, and established regulatory and ethical guidelines throughout product development. Equally important is its commitment to responsible scientific communication, ensuring that the opportunities and limitations of emerging regenerative technologies are presented with transparency. Ethical sourcing of biological materials, informed consent procedures, and patient safety remain central to this approach, reinforcing credibility in a rapidly advancing field.This culture extends beyond research. Acadicell continues to invest in mentoring young scientists, encouraging multidisciplinary collaboration, and fostering an environment where curiosity, innovation, and knowledge-sharing drive continuous improvement. By empowering researchers to think beyond experiments and focus on real-world healthcare impact, the company is nurturing the next generation of innovators alongside the technologies they develop.Looking ahead, Acadicell also sees an opportunity to con-tribute to India's emergence as a global biotechnology hub. With strong scientific talent, expanded innovation support, and growing clinical capabilities, the country is well-positioned to accelerate regenerative medicine. Acadicell aims to play a meaningful role in this ecosystem by developing globally com-petitive technologies while strengthening the bridge between academic research, industrial innovation, and patient care."Ultimately, our vision is to help shape a future where regenerative medicine becomes more accessible, reliable, and integrated into mainstream healthcare, where scientific innovation translates into hope and better outcomes for patients worldwide", concludes Dr Raghu Babu. By combining scientific excellence with ethical leadership, collaborative innovation, and a clear translational vision, Acadicell is helping shape a future where regenerative medicine moves beyond possibility to practical, accessible healthcare solutions. PO
< Page 9 | Page 11 >